ARTICLE | Company News
Receptagen deal
October 9, 1995 7:00 AM UTC
RCG (Edmonds, Wash.) signed a letter of intent with an undisclosed Japanese drug manufacturer to develop drugs to inhibit apoptosis. RCG is developing an injectable, water-soluble analog of coenzyme Q...